Current clinical trials in renal cell carcinoma

Mitchell H. Sokoloff, Siamak Daneshmand, Christopher W. Ryan

    Research output: Contribution to journalReview article

    5 Scopus citations

    Abstract

    The treatment of renal cell carcinoma remains primarily surgical. Consequently, it is not surprising that urologists have been active in the design and operation of clinical trials for patients with kidney cancer. Currently, clinical trial efforts of the urologic community are focused on the adjuvant setting in patients undergoing nephrectomy at high risk for recurrence or metastasis. As newer agents become available and are applied earlier during the course of the disease, the involvement of urologists in clinical trials in renal cell carcinoma will increase. This review highlights several key trials currently available for patients with kidney cancer.

    Original languageEnglish (US)
    Pages (from-to)289-292
    Number of pages4
    JournalUrologic Oncology: Seminars and Original Investigations
    Volume23
    Issue number4
    DOIs
    StatePublished - Jul 1 2005

      Fingerprint

    Keywords

    • Clinical trials
    • Kidney cancer
    • Nephrectomy
    • Targeted therapy

    ASJC Scopus subject areas

    • Oncology
    • Urology

    Cite this